North Amern Cannabis Hldgs Stock Price, News & Analysis
Company Description
North Amern Cannabis Hldgs (OTC Link: USMJ) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $235.4K.
USMJ stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of USMJ stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
North Amern Cannabis Hldgs (USMJ) stock last traded at $0.0000. At a market capitalization of $235.4K, USMJ is classified as a micro-cap stock with approximately 23.5B shares outstanding.
Latest News
North Amern Cannabis Hldgs has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 2 with negative movement. View all USMJ news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in North Amern Cannabis Hldgs (USMJ) currently stands at 46 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for North Amern Cannabis Hldgs (USMJ) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
USMJ Company Profile & Sector Positioning
North Amern Cannabis Hldgs (USMJ) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing USMJ often look at related companies in the same sector, including Noveris Health Sciences Inc (MYCOF), Sky Centy Invt Inc (SKYI), Real Brands (RLBD), Pazoo Inc (PZOO), and Branded Legacy Inc (BLEG). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate USMJ's relative position within its industry.